MatthewDavidTuckerMD
Internal Medicine • Birmingham, ALHematology/Oncology
Vanderbilt Hematology/Oncology Fellow
Dr. Tucker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3670 Grandview Pkwy
Birmingham, AL 35243Phone+1 205-592-5077Fax+1 205-599-4738
Education & Training
Duke University HospitalResidency, Internal Medicine, 2017 - 2019
University of Alabama School of MedicineClass of 2016
Certifications & Licensure
AL State Medical License 2022 - 2024
TN State Medical License 2020 - 2022
NC State Medical License 2016 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 18 citationsClinical Utility of FoundationOne Tissue Molecular Profiling in Men With Metastatic Prostate CancerJason Zhu, Matthew D Tucker, Daniele Marin, Rajan T. Gupta, Patrick Healy
Urologic Oncology. 2019-11-01 - 10 citationsAccelerating Implementation of Virtual Care in an Integrated Health Care System: Future Research and Operations PrioritiesAllison A. Lewinski, Caitlin Sullivan, Kelli D. Allen, Matthew J Crowley, Jennifer M Gierisch
Journal of General Internal Medicine. 2021-01-26 - 62 citationsLRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types.Landon Carter Brown, Matthew D Tucker, Ramy Sedhom, Eric B Schwartz, Jason Zhu
Journal for Immunotherapy of Cancer. 2021-03-01
Press Mentions
Androgen Deprivation Therapy May Protect Against COVID-19 in Prostate CancerJune 18th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
